Goa-based Molbio Diagnostics has launched a new test for differential diagnosis of HIV 1 and HIV 2 with viral loads within 60 minutes. The test works on the existing Truelab infrastructure and will require no additional set-ups and equipment.
Truenat is a point-of-care portable, battery-operated, IoT-enabled, Real Time PCR platform with a sample-to-result time of less than one hour. The platform can test over 35 diseases, including COVID-19, TB, Hepatitis, HIV, HPV, dengue, malaria, etc.
Sriram Natarajan, CEO, Founder and Director, Molbio Diagnostics, said, “Being a point of care platform Truenat HIV 1/ HIV 2 will provide universal access to both early detection and viral load estimation."
Dr Chandrasekhar Nair, CTO and Director, Molbio Diagnostics, said, "Truenat HIV1/HIV2 can provide test results in an hour, assuring early and accurate diagnosis of the infection."
